1---2name: precision-oncology-agent3description: <!--4---5<!--6# COPYRIGHT NOTICE7# This file is part of the "Universal Biomedical Skills" project.8# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>9# All Rights Reserved.10#11# This code is proprietary and confidential.12# Unauthorized copying of this file, via any medium is strictly prohibited.13#14# Provenance: Authenticated by MD BABU MIA1516-->1718---19name: precision-oncology-agent20description: Fuse genomic variants, pathology findings, and clinical context to draft evidence-linked therapy options for tumor board review.21allowed-tools:22 - read_file23 - run_shell_command24---2526## At-a-Glance27- **description (10-20 chars):** Tumor board copilot28- **keywords:** oncology, genomics, OncoKB, therapy-ranking, evidence29- **measurable_outcome:** Deliver a ranked therapy list with OncoKB/NCCN citations plus data-gap checklist for every case within 10 minutes of receiving inputs.3031## Inputs32- `vcf_path` (hg38 preferred) plus optional CNV/fusion summaries.33- `pathology_report` text for histology/grade/biomarkers.34- `clinical_context` dict capturing tumor type, stage, prior lines, ECOG.3536## Outputs371. Ranked treatment options (approved, off-label, clinical trials) with evidence strength + contraindications.382. Variant interpretation table (pathogenicity, tier, therapy linkage).393. Biomarker summary (TMB, MSI, PD-L1 if provided) and missing-test checklist.4041## Workflow421. **Ingest & normalize:** Harmonize gene symbols, genome build, and variant effects.432. **Annotate:** Query OncoKB/NCCN + internal knowledge for actionability tiers.443. **Contextualize:** Blend pathology + prior therapy info to filter contraindicated options.454. **Recommend:** Present therapies ordered by evidence + patient fit; cite sources.465. **Gaps:** Highlight assays or confirmations still required before treatment.4748## Guardrails49- No autonomous treatment decisions—flag outputs as advisory.50- Cite evidence rigorously (guideline version, publication).51- Highlight resistance mechanisms and prior exposure conflicts.5253## References54- See `README.md` for detailed workflow plus cited Nature Cancer study.555657<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->